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ABSTRACT: We provide an overview of 13C magnetic resonance spectroscopy methods
and their applications as an established metabolic tool with an emphasis on the use of
high-resolution 13C magnetic resonance spectroscopy and 13C isotopomer analysis. Topics
addressed include general properties of the 13C magnetic resonance spectroscopy spec-
trum; different 13C magnetic resonance spectroscopy acquisition protocols; determination
of fractional 13C enrichment, kinetic, or steady state measurements of metabolic flux; 13C
isotopomer analysis approaches; 13C(2H) magnetic resonance spectroscopy methodologies;
and in vivo 13C magnetic resonance spectroscopy. Some illustrative applications are
described. © 2005 Wiley Periodicals, Inc. Concepts Magn Reson Part A 27A: 1–16, 2005
KEY WORDS: 13C MRS; isotopic dilution; isotopomer analysis; tricarboxylic acid cycle;
glutamine cycle; hydrogen turnover
INTRODUCTION
The first 13C magnetic resonance spectroscopy (13C
MRS) study of a living organism was probably re-
ported in 1972 (1). Authors followed the metabolism
of (1-13C) glucose by a eukaryotic cell system and
concluded that the use of this pioneering technique
“could have numerous applications for in vivo meta-
bolic studies.” Since then, 13C MRS has developed
steadily to a method routinely used in metabolic re-
search with cells, perfused organs, animals, and even
humans (2–5). This progress has been favored by the
ability of 13C MRS to (i) perform repetitive, nonin-
vasive measurements of metabolic processes as they
proceed in their own intracellular environment and (ii)
its capacity to measure unique physical properties not
detectable by other methodologies, such as spin cou-
pling patterns, isotopic shifts, or magnetic relaxation
times T1 and T2. These properties have been shown to
provide valuable information on the operation in situ
of specific metabolic pathways or the dynamics of
some important biological assemblies, exceeding in
many cases the interpretations provided by previously
used radioactive, spectrophotometric, or fluorimetric
approaches.
13C MRS allows detecting magnetic resonances
from 13C, the only stable isotope of carbon having a
magnetic moment. The natural abundance for 13C is
roughly 1.1% of the total carbon and its magnetogyric
ratio is approximately one-fourth of that of the proton.
These two circumstances make 13C MRS an insensi-
tive technique (6 ). Despite this, natural abundance
13C resonances from carbons of the fatty acid chains
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of triglycerides are classically observed in most tis-
sues, and glycogen carbons can be detected in the
liver and muscle of fed animals and man (2, 3, 7 ). The
sensitivity problem can be improved markedly by
using 13C enriched substrates. The combination of 13C
MRS detection and substrates selectively enriched in
13C in specific positions have made it possible to
follow in vivo and in vitro the activity of a large
variety of metabolic pathways in cells, animals, and
humans. These include glycolysis and the pentose
phosphate pathway, glycogen synthesis and degrada-
tion, gluconeogenesis, the tricarboxylic acid cycle,
ketogenesis, ureogenesis and the glutamate, glu-
tamine, GABA cycle in brain, and others (see refer-
ences [2–4] for reviews).
The design of 13C MRS experiments with selec-
tively 13C-enriched substrates is similar to the classi-
cal radiolabeling experiments using 14C. A relevant
difference is that 13C precursors are administered in
substrate amounts, whereas 14C substrates are used in
tracer amounts. However, 13C MRS presents impor-
tant advantages over 14C. First, the metabolism of the
13C-labeled substrate can be followed in real time, in
situ, and noninvasively (4, 5 ). Second, even if tissue
extracts are prepared, the detection of 13C in the
different carbon resonances of a specific metabolite
does not require separation and carbon by carbon
degradation, a prerequisite in the experiments with
radioactive 14C (8 ). Finally, the analysis by 13C MRS
of homonuclear spin-coupling patterns and isotope
effects allows investigation if two or more 13C atoms
occupy contiguous positions in the same metabolite
molecule. The latter approach represents, as will be
illustrated later in this article, an enormous gain in
information as compared with the classical radioac-
tive 14C experiments (8 ). As a counterpart to these
advantages, 13C MRS is significantly less sensitive
than other conventional metabolic techniques, such as
radioactive counting, mass spectrometry, and spectro-
photometric or fluorimetric methods.
The purpose of this article is to provide an intro-
duction to 13C MRS methods and applications with
particular reference to high-resolution 13C NMR and
13C isotopomer approaches. The methodology de-
scribed here refers mainly to studies performed with
tissue extracts but provides an adequate framework to
understand the approaches used with in situ animals
and human beings. More information on the latter
aspects may be found in references (9–12) or in NMR
in Biomedicine’s 2003 special issue titled “13C NMR
Studies of Cerebral Metabolism.” Other reviews
cover in more detail the metabolic information de-
rived from 13C isotopomer analysis in the adult mam-
malian brain (13) or in primary cultures of neural cells
(14, 15).
METHODOLOGY
The 13C MRS Spectrum: Spin Coupling
Patterns and Isotopic Shifts
13C resonances are distributed over a large chemical
shift range and experience low relaxation rates (16).
Normally, high-resolution 13C MRS spectra of metab-
olites depict a collection of well-resolved narrow res-
onances distributed over large chemical shift range
( 250 ppm), even in viscous media as those found in
vivo.
Figure 1 shows typical proton-decoupled 13C MRS
spectra of perchloric acid extracts obtained from the
brain of rats infused with (1,2-13C2) glucose [see Fig.
1(A)] or (1,2-13C2) acetate [see Fig. 1(B)] as com-
pared with the natural abundance 13C MRS spectrum
of a rat infused with unlabeled glucose (17). The most
important resonances detected are those from the car-
bons of glutamate, glutamine, GABA, NAA, inositol,
and glucose. The increased intensity of the resonances
observed in the upper panels clearly indicates that the
13C label has been incorporated in cerebral metabo-
lites. Indeed, the difference between the intensity of
the natural abundance signal and the total intensity of
the corresponding multiplet resonance in the spectrum
obtained with 13C-labeled substrate reveals the net
amount of 13C incorporated in the corresponding car-
bon. Most of the resonances observed in the upper
panel of Fig. 1 depict an apparent triplet structure
produced by homonuclear 13C-13C coupling. These
pseudotriplets are derived from the superposition of
doublets originated in those metabolites containing
two contiguous 13C atoms in the same molecule or
from singlets, corresponding to those metabolites con-
taining the 13C atom bonded to 12C neighbors.
Figure 2 and reference (13) illustrate more clearly
these aspects. If pathway A incorporates one 13C atom
from the labeled substrate in position i of metabolite
M, a singlet resonance will appear at frequency i. If
by any chance the 13C atom from the substrate is
incorporated through a different mechanism (pathway
B) in position i 1 of M, a new singlet resonance will
appear, now located at a different frequency i  1 in
the 13C MRS spectrum. It becomes then possible to
determine the relative contributions of pathways A
and B to the formation of M by the relative intensities
of the 13C resonance at i to that of i  1. If pathways
A and B are both active, 13C atoms may be incorpo-
rated simultaneously at positions i and i  1 of the
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same metabolite molecule. In this case, a new inter-
action appears between the adjacent magnetic mo-
ments of contiguous 13C nuclei. This interaction splits
the original singlet resonances into doublets. This is
so because the multiplicity of 13C resonance coupled
to nucleus X is given by the rule 2nI  1, where n is
the number of X nuclei coupled to 13C, and I is their
angular momentum (I 1/2 for X 1H, 31P, 13C, 15N
or I  1 for X  2H). This interaction is known as
homonuclear scalar coupling and is transmitted
through the electrons of the 13C-13C-bond.
13C MRS Acquisition: 1H Decoupling and
NOE Enhancement
Figure 3 illustrates the most important characteristics
of 13C MRS data acquisition and the resulting 13C
MRS spectra for the hypothetical case of a 13C carbon
bonded only to a vicinal proton. Spin coupling to one
or more protons complicates the interpretation of the
13C spectra and thus it is normally removed using a
variety of proton decoupling techniques. All decou-
pling procedures are based on the same principle, the
broadband irradiation of all proton resonances with a
high-power amplitude-modulated and monochromatic
1H frequency. The irradiation saturates the Boltzman
energy levels of the proton spectrum, removing the
macroscopic magnetization of all protons and making
the scalar proton couplings disappear from the 13C
spectrum. There are two main proton decoupling
methods: broad band decoupling (BB) and composite
pulse decoupling (WALTZ). They differ in the type of
modulation of the proton frequencies. Whereas BB
uses a continuous irradiation of proton frequencies
with a train of rectangular pulses of identical duration
and opposite phase (16), composite pulse decoupling
uses blocks of 1H pulses of different pulse lengths and
phases (18). WALTZ sequences are more efficient
than BB, allowing decoupling 13C spectra using less
decoupler power and diminishing also the potential
dielectric heating of the sample. In addition to the
removal of scalar 1H couplings, 1H irradiation can
cause an increase in the 13C signal intensity because
of the nuclear overhauser enhancement effect
(NOE). The NOE effect is a magnetization transfer
process from 1H to 13C, which may increase the
Figure 1 13C MRS spectra (90.55 MHz, 22 0C, pH 7.2) of brain extracts after infusion of
(1,2-13C2) glucose (A), (1,2-13C2) acetate (B), or unlabeled glucose (C). Gln C3 (26.87, 1J23 
1J34  34.5), Glu C3 (27.80, 1J23  1J34  34.5), Gln C4 (31.60, 1J34  34.5, 1J45  49.0), Glu
C4 (34.16, 1J34  34.5, 1J45  51.0), GABA C2 (35.07, 1J12  51.0), Gln C2 (55.0, 1J12  54.96,
1J23  34.5), Glu C2 (55.35, 1J12  53.0, 1J23  34.5). Numbers in parenthesis give the chemical
shift in ppm, followed by the geminal coupling constant(s) in Hz. Insets in C: Natural abundance
contribution of unlabeled GABA in the spectra of vigabatrin treated animals. Ala: alanine, Asp:
aspartate, GABA: -aminobutyric acid, Gln: glutamine, Glu: glutamate, NAA: N-acetylaspartate,
Tau: taurine. Reproduced from (17 ) with permission of the publisher.
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intensity of a 13C resonance up to threefold in
favorable cases. More information on decoupling
sequences and NOE enhancement in 13C MRS is
given in the classical monograph by Breitmeier and
Voelter (16 ).
Different decoupling schemes are possible that
produce proton-coupled or proton-decoupled 13C
MRS spectra containing (or not containing) NOE
enhancement. If the 1H decoupler is not used in con-
junction with 13C excitation (see Fig. 3, top panel), a
proton-coupled 13C spectrum is obtained. The multi-
plet structure of the proton-coupled 13C resonance
depends of the number of protons coupled to the
observed carbon and follows the rule, 2nI  1. For
n  1, a doublet is obtained. If the decoupler is gated
only during the acquisition of the 13C FID (inverse
gated decoupling), a proton-decoupled spectrum de-
void of NOE is obtained. On the contrary, if the
decoupler is gated only during the relaxation delay
and not during the acquisition (direct gated decou-
pling), a proton-coupled NOE-enhanced 13C spectrum
is obtained. Inverse-gated decoupling avoids the ef-
fects of NOE, whereas direct-gated decoupling gen-
erates 1H-coupled 13C spectra with complete NOE
enhancement. Decoupling during the complete cycle
time generates a proton-decoupled NOE-enhanced
13C spectrum (19).
A different strategy was proposed in 1985 by Roth-
man et al. (20). These authors showed that 13C-la-
beled metabolites could be detected in vivo with 1H
sensitivity using a 13C decoupling sequence in con-
Figure 2 Homonuclear coupling patterns in two contigu-
ous carbons of the same metabolite molecule. (A) 13C-12C;
(B) 12C-13C; (C) 13C-13C.
Figure 3 Acquisition of 13C MRS spectra under different 1H-decoupling conditions. Top: proton-
coupled 13C MRS spectrum; middle: proton-decoupled 13C MRS spectrum without NOE; bottom:
proton-decoupled 13C MRS spectrum with NOE. The 13C or 1H symbols at the left of every
sequence indicate RF transmitter or decoupler pulses, respectively.
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junction with 1H detection (POCE; proton observed
carbon edited). Since then, this approach has been
used successfully in vivo and in vitro, and several
examples are available in the literature (21, 22).
13C MRS Quantitation
The interpretation of 13C MRS spectra in terms of flux
through metabolic pathways requires the quantitation
of the 13C incorporated in specific carbons. This is
normally done by expressing 13C incorporation as a
fractional 13C enrichment in carbon Ci (YCi). The
fractional 13C enrichment YCi is defined as the amount
of 13C relative to the total carbon (13C12C) present
in Ci.
YCi
13C concentration in Ci
13C  12C concentration in Ci
[1]
The measurement of YCi involves (i) the determina-
tion of 13C concentration by 13C MRS methods and
(ii) the measurement of the total carbon concentration
by more conventional techniques (automatic ion ex-
change chromatography for amino acids, HPLC, en-
zymatic end point methods for other metabolites, and
so on).
Special precautions must be taken in the determi-
nation of the concentration of 13C in Ci by 13C MRS
because 13C signal intensities depend on various fac-
tors, in addition to the 13C concentration. Thus, 13C
resonances from carbons with the same 13C concen-
tration may have different intensities or areas depend-
ing on the particular pulsing condition used, the re-
laxation behavior of the observed carbon, its NOE
effect, and acquisition and repetition times.
The intensity, area, or magnetization M(t) of a 13C
carbon resonance is given by Eq. [2] (23):
Mt  M0
sin et/T1 1
et/T1 1
 	 11 e
a/T1e
t/T1 [2]
where M(t) is the area of the resonance under the
pulsing conditions used, M(0) is the area of the reso-
nance under equilibrium magnetization conditions, 
is the flip angle used in the 13C pulse, 	 is the NOE
enhancement factor, t is the total cycle time, T1 is the
longitudinal relaxation time, and a is the acquisition
time. M(0) is proportional to the concentration of 13C.
Thus, if the 13C spectrum is acquired under fully
relaxed conditions, a comparison of the area M(0) in
the sample with the area of the same resonance in a
standard solution of known concentration would give
a value for the 13C concentration in the sample. In
practice, this procedure is not recommended because
T1 values of 13C in extracts vary from approximately
3 s in methyl and methylene resonances to 30 s or
more in quaternary carbons like those of carboxylic
acids. Thus to recover completely the equilibrium
magnetization M(0) in the sample, the slowest car-
bons would require a total cycle time of approxi-
mately 150 s. This is incompatible with reasonable
acquisition times. Thus, a compromise is normally
adopted and M(0) in the sample and standard solu-
tions can be calculated from M(t) measured under
partially saturating conditions (3–6 s total cycle time)
and predetermined values of T1 and  using the
equation described above. To favor quantitation, the
influence of the NOE factor is avoided using gated
decoupling sequences.
Other 13C MRS quantitation strategies may be used
to determine fractional 13C enrichments: (i) direct
comparison of the areas of the 13C resonances in the
sample spectrum with those of the same resonances in
the spectrum of a standard solution of known concen-
tration acquired under identical pulsing conditions;
(ii) comparison of the intensities of 13C resonances in
the sample spectrum with the intensity of the natural
abundance signals (1.1% YCi) from an experiment
performed using an unlabeled substrate; and (iii) use
of 1H MRS to measure the relative area of the 13C
satellites to the total area of the 1H resonance (see
below). Once the 13C concentration is known, the
fractional 13C enrichment can be calculated and used
in mathematical models of metabolism to determine
metabolic flux.
DETERMINATION OF METABOLIC FLUX
BY 13C MRS
Kinetic and Steady-State Methods
The main goal of 13C MRS studies is to explore
qualitatively or quantitatively metabolic flux through
a specific step in a pathway, through a whole pathway,
or through a combination of several pathways. To
measure metabolic flux by in vivo 13C MRS, a 13C-
enriched precursor is administered (infused, peri-
fused, and injected) to the biological system. After its
administration, 13C atoms from the substrate substi-
tute progressively, because of metabolism, the 12C
atoms previously present in the system. This substi-
tution may be monitored kinetically in some favorable
cases by 13C MRS techniques (24–27).
Once the kinetics of 13C enrichment are known it
becomes possible to fit the time course of 13C enrich-
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ment(s) to a metabolic model containing the fractional
13C enrichment(s) as the dependent variable(s), time
as the independent variable, and the unknown fluxes
as the parameters to be fitted. This approach allowed
calculating the flux through the tricarboxylic acid
cycle and the glutamine cycle in the brain of animals
and man (9, 25, 26).
Eventually, an isotopic steady state is achieved
after continuous administration of a 13C-enriched sub-
strate. Under steady-state conditions, the rate of in-
corporation of 13C equals the rate of disappearance,
and principles of conservation of mass and isotope are
fulfilled (Fig. 4).
These principles state that the total amount of
carbon (13C  12C) and the amount of 13C entering a
carbon pool are equal to the total amount of carbon
(13C  12C) and 13C leaving the pool, respectively. It
is possible then to set up a series of simultaneous
equations relating the fractional 13C enrichments de-
termined in every carbon to input output fluxes (see
Fig. 4). The unknown fluxes can be found, provided
the number of equations is equal to the number of
unknowns. This is many times the limiting condition
as the number of fractional 13C enrichments deter-
mined by 13C MRS or directly measurable fluxes by
other conventional methods is small in comparison
with the complexity of metabolic transformations in-
vestigated. In these cases, the use of simplified models
of metabolism has proven to be useful. Examples of
the steady-state approach based of isotopic dilution
can be found in the classic work of Chance et al. (27)
or studies of neural cell metabolism (28, 29).
The 13C Isotopomer Approach
The methods based exclusively on the determination
of fractional 13C enrichment neglect the information
provided by spin coupling patterns (see Fig. 2), re-
sulting in a significant loss of information. Thus, for a
five-carbon metabolite such as glutamate, 13C enrich-
ment determinations would produce at most five dif-
ferent enrichment values, one for every carbon. These
number enrichments would support at most five input-
output equations as described in Fig. 4.
The gain in information introduced by the use of
spin coupling patterns or isotopic shifts is more easily
perceived with the following example. For a molecule
such as glutamate containing five carbons, five hydro-
gens, four oxygens, and one nitrogen atom, the pos-
sibilities of isotopic substitution with 13C, 2H, 17O,
and 15N isotopes are large (Table 1). Glutamate has 32
possibilities of 13C labeling. Each of these possibili-
ties is an isotopic isomer (or isotopomer) of glutamate
with 32 possibilities of deuteration, four possibilities
of 17O (or 18O) labeling, and two possibilities of
nitrogen substitution. Thus, a total of 32,768 isoto-
pomers of (13C, 2H, 17O, 15N) glutamate are available
for labeling in multinuclear studies. Fortunately, not
all of these isotopomers are directly detectable by
conventional 13C MRS methods. Only about 40 iso-
topomers of (2H,13C) glutamate are easily detected in
1D 13C MRS with combined 13C and 2H labeling;
more would be detectable using more sophisticated
2D or 3D multinuclear MRS techniques. Input-output
equations for each of these isotopomers can be written
and solved, allowing a significantly larger number of
fluxes to be determined than with the conventional
fractional enrichment method. However, the large
number of equations demands the use of computer
programs to calculate and fit simulated 13C spectra to
Figure 4 Principles of mass conservation and isotope con-
servation at steady state. YCn, YCm, and YCp refer to
fractional 13C enrichments in carbons Cn, Cm, and Cp. Fz
or Fx and Fy refer to metabolic fluxes leaving and entering
the Cp pool, respectively. Mass conservation principle:
Fz  Fx  Fy. Isotope conservation principle: YCp.Fz 
YCn.Fx  YCm.Fy. If Fz is known, Fx and Fy can be
calculated if YCp, YCm, and YCn are measured by 13C
MRS.
Table 1 Possibilities of Isotopic Substitution in
Glutamate
Atom Number
Isotopic
Substitution
Possibilities of
Isotopic
Labeling
(Isotopomers)
Carbon 5 13C 32
Hydrogen 5 13C, 2H 1,024
Oxygen 4 13C, 2H, 17O(18O) 16,384
Nitrogen 1 13C, 2H, 17O(18O),
15N
32,768
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experimental ones. At least two algorithms are avail-
able that perform this task, TCASIM (30) and META-
SIM (31). The isotopomer approach was initially de-
veloped for the estimation of the contribution of
anaplerotic fluxes to the tricarboxylic acid cycle of the
heart (32) and has been extended to the study of
metabolic compartmentation in heart (33–36) and
brain (13, 28, 37–41). In addition, 2H-13C couplings
have been used in the study of solvent exchange
reactions in the perfused liver (42, 43), and 15N-13C
and 1H-15N couplings in the analysis of ammonia
detoxification pathways (44, 45).
APPLICATIONS
Cerebral Metabolic Compartmentation as
Revealed by the Use of Substrates
Multiply Enriched in 13C and High-
Resolution 13C MRS
A significant number of studies of cerebral metabolic
compartmentation have used high-resolution 13C
MRS analysis of brain extracts and glucose or acetate
contiguously labeled with 13C as cerebral substrates
(13, 17, 31, 37–41). An important basis for the use of
this approach is the impressive amount of metabolic
information contained in homonuclear spin coupling
patterns.
Figure 5 provides an adequate frame to discuss
these aspects by showing schematically the cerebral
metabolism of (1,2-13C2) glucose or (1,2-13C2) acetate
and their effects on 13C MRS spectra of brain extracts.
(1,2-13C2) glucose is transported from plasma to brain
cells through glucose transporters and degraded di-
rectly to an equimolar mixture of (2,3-13C2) and un-
labeled pyruvate through the Embden-Meyerhoff
pathway. Cytosolic (2,3-13C2) pyruvate can be re-
duced to (2,3-13C2) lactate, transaminated to (2,3-
13C2) alanine, or transported to the mitochondria for
oxidative metabolism (46). In the mitochondrial ma-
trix, (2,3-13C2) pyruvate can enter the tricarboxylic
acid cycle through pyruvate dehydrogenase as (1,2-
13C2) acetyl-CoA or through pyruvate carboxylase as
(2,3-13C2) oxalacetate. In the first turn, (1,2-13C2)
acetyl-CoA produces (4,5-13C2) 
ketoglutarate,
while (2,3-13C2) oxalacetate forms (1,2-13C2) 
ke-
toglutarate. The exchange between -ketoglutarate
and glutamate, through aspartate aminotransferase,
has been traditionally assumed to be fast compared
with the tricarboxyxlic acid flux, and thus glutamate
labeling is thought to reflect accurately the labeling in
the -ketoglutarate precursor (22). Thus (4,5-13C2)
and (1,2-13C2) glutamate reflect 13C labeling of the
corresponding -ketoglutarate precursors. (4,5-13C2)
and (1,2-13C2) glutamate may produce (4,5-13C2) and
(1,2-13C2) glutamine through glutamine synthase or
(1,2-13C2) and (4-14C) GABA through glutamate de-
carboxylase, respectively. If (4,5-13C2) or (1,2-13C2)
-ketoglutarate continue metabolism through the cy-
cle, equimolar mixtures of (3,4-13C2) and (1,2-13C2)
or (1-13C) and (4-13C) succinates, fumarates, and
malates are produced, entering eventually a new turn
of the cycle. Several studies of cerebral metabolism
used (1,2-13C2) acetate as substrate (37–40). (1,2-13C2)
acetate is believed to be transported and activated to
(1,2-13C2) acetyl-CoA only in glial cells, bypassing the
pyruvate dehydrogenase and pyruvate carboxylase steps
of entry into the tricarboxylic acid cycle.
These 13C labeling patterns are adequately re-
flected in the high-resolution 13C MRS spectra of
brain extracts by the intensities and multiplicities of
the 13C resonances from the individual carbons of
glutamate, glutamine, and GABA. This is illustrated
in Fig. 1, which shows representative 13C MRS spec-
tra obtained from brain extracts after metabolism of
(1,2-13C2) glucose (A), of (1,2-13C2) acetate (B), or of
unlabeled glucose (bottom). At steady state, glutamate
carbons C4 (34.2 ppm) and C5 (182.2 ppm) reflect
labeling of acetyl CoA carbons C2 and C1, whereas
glutamate carbons C1 (175.5 ppm), C2 (55.5 ppm),
and C3 (27.7 ppm) reflect labeling in oxalacetate
carbons C4, C3, and C2, respectively. The relative
proportions of (2,3-13C2) pyruvate entering the tricar-
boxylic acid cycle through pyruvate dehydrogenase or
pyruvate carboxylase can be estimated by the relative
intensities of the doublet resonances observed in the
glutamate C4 and C2 carbons, respectively (47, 48).
In addition, 13C MRS spectra of brain extracts
provide an excellent tool to study cerebral metabolic
compartmentation. This is more easily accomplished
through the analysis of the homonuclear spin coupling
patterns. Indeed, most of the observed resonances in
Fig. 1 display an apparent triplet structure derived
from the superposition of doublets and singlets. Dou-
blets arise from contiguously 13C-labeled isotopomers
of glutamate, glutamine, and GABA, whereas singlets
are derived from the corresponding isotopomers with
13C carbons having only 12C neighbors. The presence
of cerebral compartmentation is easily demonstrated
through the analysis of the glutamate and glutamine
C3 and C4 carbon resonances. When (1,2-13C2) glu-
cose is the substrate, the different singlet/doublet ratio
in the glutamate and glutamine C3 carbons is incon-
sistent with a single pool of acetyl-CoA and oxalac-
etate condensing at the citrate synthase step of a
unique cerebral tricarboxylic acid cycle. Similarly,
when (1,2-13C2) acetate is the substrate, the singlet/
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doublet ratio in glutamine C4 is clearly different from
that of its precursor glutamate C4, a result inconsistent
with the presence of a unique glutamate pool. This
difference led to the description of the cerebral pyruvate
recycling system, a pathway transforming (1,2-13C2)
acetyl-CoA units in (1-13C) and (2-13C) acetyl-CoA
units, which occurs mainly in the synaptic terminals (37,
49). More quantitative interpretations can also be per-
formed with the help of programs for computer-assisted
interpretations of 13C MRS spectra (13, 31).
Hydrogen Turnover as Studied
by 13C MRS
As described previously, several 13C MRS techniques
have been implemented to study the turnover of indi-
Figure 5 Cerebral metabolism of (1,2-13C2) glucose and (1,2-13C2) acetate. Filled circles indicate 13C.
Empty circles indicate 12C. Only the first turn of the tricarboxylic acid cycle is considered. Contiguously
labeled isotopomers of glutamate, glutamine and GABA originate the doublet resonances observed in
Fig. 1. Single-labeled and natural abundance isotopomers originate singlet resonances in Fig. 1. PDH:
pyruvate dehydrogenase, PC: Pyruvate carboxylase, ME: malic enzyme, PEPCK: phosphoenolpyruvate
carboxykinase, PK: pyruvate kinase. Reproduced from (13) with permission of the publisher.
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vidual metabolite carbons by using precursors selec-
tively enriched in 13C. Because most metabolite car-
bons are attached to one or more hydrogen atoms, 13C
MRS could also serve as a valuable tool to analyze
hydrogen turnover. This is a much faster process than
13C turnover and therefore allows studying faster re-
actions. Our laboratory has proposed a double-label-
ing strategy to investigate hydrogen turnover. Our
approach follows by 13C MRS the exchange of pre-
existing 1H by 2H at the steady state, when metabo-
lism occurs in media containing a 13C-labeled sub-
strate and 2H2O (40, 42, 43, 50–52). This is possible
because high-resolution 13C MRS is well suited to
detect complex deuteration patterns in 13C-labeled
metabolites.
The presence of one or more deuterons geminally
or vicinally bound to the observed 13C implies the
appearance of characteristic 2H isotopic shifts and
2H-13C couplings (50, 51, 53). Therefore, coupling
patterns to 2H may appear as splitted and/or shifted
resonances in relation to the preprotonated 13C reso-
nance. Figure 6 depicts this behavior. If one of the
protons directly bonded to 13C is substituted by 2H,
the original resonance is splitted into a 1:1:1 triplet
(19.21  1JC–H  22 Hz), inducing a geminal upfield
isotopic shift (
0.25  1  
0.33 ppm). Two or
three deuterons bound to the same 13C atom would
result in additive isotopic shifts and 2H-13C couplings
patterns of five or seven line multiplets, shifted by

0.5 or 
0.75 ppm, respectively. Even a vicinal
deuterium substitution induces smaller and additive
upfield isotopic shifts (
0.03  2  
0.11 ppm).
Vicinal couplings to deuterium are too small to be
resolved, and resonances shifted vicinally maintain
the multiplet structure of their geminal couplings.
Thus high-resolution 13C MRS allows determining
the number of deuterium replacements, their relative
contributions, and their geminal or vicinal location
with respect to the observed 13C carbon of a specific
13C isotopomers through the analysis of shifted and
unshifted (1H,2H)13C multiplets.
This kind of approach makes it possible to develop
novel procedures to investigate and resolve in time
fast metabolic processes, as long as they involve ex-
change of hydrogens by deuterons. In our laboratory,
we have monitored the dynamics of exchange from
specific hydrogens of hepatic glutamate and aspartate
with deuterons from intracellular heavy water. With
this approach it became possible to observe directly
-ketoglutarate/glutamate exchange and oxalacetate/
aspartate exchange and subcellular compartmentation,
by following in a time-resolved manner the sequence
of events involved in the traffic of these metabolites
through mitochondria and cytosol (42). In this work,
the determination of relative (1H,2H,13C) isotopomer
populations is conveniently accomplished using a
simulation program, which allows the quantitative
determination of the relative contributions of the in-
dividual (1H,2H)13C multiplets. Figure 7 shows a rep-
resentative deconvolution of the C2 carbon resonance
of (2-13C) glutamate. Deconvolution of the C2 carbon
resonance revealed contributions from five different
(1H,2H,13C) glutamate isotopomers. Notably, these
results reveal intracellular glutamate compartmenta-
tion and slow -ketoglutarate/glutamate exchange, a
circumstance not considered previously.
Figure 8 illustrates the kinetics of deuteration of
the H2 and H3 hydrogens from (2-13C) glutamate
during perfusions with (3-13C) alanine in Krebs-
Ringer bicarbonate (KRB) buffer containing 50%
2H2O. The faster timescale of hydrogen exchange
allows resolving in time cytosolic deuteration, as
those of (2-13C, 3-2H) glutamate, and mitochondrial
deuterations, as that of (2-13C, 3,3-2H2) glutamate
(42).
Figure 6 2H-13C multiplets and deuterium-induced isoto-
pic shifts in proton-decoupled 13C MRS spectra. (A) prep-
rotonated carbon, (B) vicinal deuteration, (C–E) geminal
deuteration by one, two, or three deuterons. Simulations
were performed with the program WINDAISY using the
following parameters: 1JC–H  20.06 Hz; geminal isotopic
shift, 1
22.89 Hz/deuteron; vicinal isotopic shift, 2

9.89 Hz/deuteron. Reproduced from (50) with permission
of the publisher.
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In Vivo 13C MRS and Clinical 13C MRS
The possibility to obtain 13C MRS spectra of metab-
olism as it proceeds in its own intracellular environ-
ment, in animal models or in human beings, repre-
sents one of the most attractive possibilities of the 13C
MRS method. Although 13C MRS can be performed
in natural abundance conditions, studies with admin-
istration of exogenous 13C-enriched precursors are
more common. If a 13C label is delivered adequately
to an in vivo system, the incorporation of the 13C label
Figure 7 Representative deconvolution of the C2 carbon resonances from (2-13C) glutamate into the
contributions of individual (1H,2H)13C multiplets. 13C MRS spectra (150.90 MHz, 22°C, pH 7.2) were
obtained from the extracts of single livers perfused with 6 mM (3-13C) alanine in 50% 2H2O for 15 min
(C2 glutamate). Relative contributions of specific isotopomers are given as the fractional contribution of
the corresponding multiplet to the total area of the analyzed resonance taken arbitrarily as one.
Simulations were performed with the WINDAISY program. s: singlet, ss: shifted singlets, dss: doubly
shifted singlet, t: triplet, st: shifted triplet. Reproduced from (42) with permission of the publisher.
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into some relevant metabolites can be dynamically
detected in situ by direct 13C MRS or inverse (1H) 13C
MRS.
A large number of studies using in vivo 13C MRS
has been performed in the intact rodent or human
brain. Surface coils constitute the most widespread
localization technique, improving the sensitivity and
avoiding external interferences (54, 55). 13C MRS 3D
localization of a selected volume constituted an im-
portant methodological challenge approached by sev-
eral laboratories during the past decade. Parallel to the
development of 3D localization, recent improvements
in localized shimming provided an additional contri-
bution to the advance of the technique (56, 57). Both
improvements were fundamental to obtain relevant
results, opening the field of in vivo 13C MRS as one
of the most powerful techniques in noninvasive stud-
ies of neurological processes. Contributions from this
technology include (i) observation of the natural
abundance signals from some brain metabolites in
vivo (e.g., myo-inositol) (54); (ii) in situ detection of
(1-13C) glycogen in the intact brain (58); and (iii)
development of noninvasive studies of cerebral met-
abolic compartmentation, as 13C labeling of cerebral
glutamate and glutamine can be visualized in vivo
(57, 59).
More recently, 13C MRS approaches have contrib-
uted significantly to our understanding of neuronal-
glial interactions in brain (26, 41, 60, 61). A brief
Figure 8 Kinetics of deuteration of the H2 and H3 hydro-
gens from (2-13C) glutamate. Fractional contributions of
individual isotopomers in each time point were determined
as described in the legend to Fig. 7 and are indicated by
specific symbols (insets). Lines represent the best fit to a
minimal model of hydrogen exchange. Multiplicities are
abbreviated as indicated in Fig. 7. Reproduced from (42)
with permission of the publisher.
Figure 9 Metabolic coupling between neurons and glia. Glutamatergic neurotransmission releases
glutamate from the synaptic vesicles to the synaptic cleft. Synaptic glutamate may be then
recaptured by specific astrocyte transporters (together with 3Na) to produce glutamine through
glutamine synthase. Glial glutamine is released to the extracellular space and taken up by neurons,
closing the glutamate-glutamine cycle. ATP required for glutamine synthesis (and Na extrusion)
is produced in the astrocyte by degrading plasma glucose, both oxidatively and nonoxidatively.
Thus, glutamatergic neurotransmission is coupled to the intercellular glutamine cycle and astrocytic
glucose uptake. GLC: glucose, GLN: glutamine, GLU: glutamate, LAC: lactate, TCAg: glial
tricarboxylic acid cycle, TCAn: neuronal tricarboxylic acid cycle.
AN OUTSTANDING TOOL FOR METABOLIC STUDIES 11
summary is outlined in Fig. 9. Following activation,
neurons release glutamate to the synaptic cleft, which
either binds to postsynaptic receptors or is recaptured
by surrounding astrocytes in the neuropil. Astrocytic
glutamate is transformed into glutamine by the ATP-
dependent glutamine synthase, glutamine being ex-
truded from the astrocyte and recaptured by the neu-
ron. Together, these processes constitute the
glutamate-glutamine cycle that underlies the coupling
of neuronal and glial metabolisms. The neuronal and
glial tricarboxylic acid cycles and the glutamine cycle
and been investigated repeatedly by in vivo and in
Table 2 Tricarboxylic Acid Cycle and Glutamate/Glutamine Exchange between the Neuronal Glial
Compartments of the Adult Brain as Calculated with Different Models and Methodologies
Process/Model Garfinkela
Van den
Berg and
Garfinkelb
Kunnecke
et al.,c
Preece and
Cerdand
Mason et al.,e
Sibson et
al.,f,g Shen et
al.,h Lebon et
al.i
Gruetter
et al.k
Bluml
et al.m
Total cerebral TCA cycle flux
(mol min
1 g
1) 1.05 1.5 1.4
1.6 or 0.7,e
0.6,f 1.0–0.2,g
0.8h 0.6 0.84
Neuronal TCA cycle flux
(mol min
1 g
1) 0.40 1.2 1.0
1.6,e 0.6,f
1.0–0.2,g 0.8h 0.6 0.70
Glial TCA cycle flux
(mol min
1 g
1) 0.65 0.3 0.4 0.14i 0.14
Size (mol g
1)/turnover
(min
1) of large glutamate
pool 8.8/21.7 7.0/5.7 5.8/5.8 n.a. n.a.
Size (mol g
1) turnover
(min
1) of small glutamate
pool 1.7/2.6 1.25/4.16 0.5/1.25 n.d./7.7j n.a.
Net transfer of neuronal gluta-
mate to glial compartment
(mol min
1 g
1) 0.08n 0.14 0.1
0.21,f 0.40–
0.0,g 0.32,h
0.3i 0.3 (0.2)l n.a.
Net transfer of glial glutamine to
neuronal compartment
(mol min
1 g
1) 0.45 n.a. 0.1
0.21,f 0.40–
0.0,g 0.32,h
0.3i 0.3 (0.2)l,m n.a.
a Calculated from specific radioactivity measurements in brain extracts obtained after intracraneal injections of various radioactive
precursors including (U-14C) glutamate, (U-14C) aspartate, 14CO3H
, and 15NH4 acetate (69).
b Calculated from specific radioactivity measurements in glutamate, glutamine, and aspartate from mouse brain extracts prepared after
intraperitoneal injections of 14C-labeled glucose and acetate (70).
c Relative flux values were calculated as described in (31) and from the relative 13C isotopomer populations in glutamate, glutamine, and
GABA measured by high-resolution 13C NMR in rat brain extracts after infusion of (1,2-13C2) acetate (38 ).
d Absolute flux values were determined from the relative values described in note (c) by measuring the absolute rate of GABA
accumulation induced by vigabatrin, a selective inhibitor of GABA transaminase (17 ).
e Determined in vivo from the kinetics of 13C enrichment in glutamate and glutamine C4 carbons from rat or human brain during infusion
of (1-13C) glucose, respectively (21, 25 ).
f Determined in vivo from the kinetics of 13C labeling in glutamate and glutamine C4 (55 ).
g Determined in vivo from the kinetics of 13C enrichment in glutamate and glutamine C4, under different conditions of morphine,
-chloralose, and pentobarbital anesthesia (71).
h Determined in the human brain in vivo during (1-13C) glucose infusion. Glutamate/glutamine exchange concluded to be stoichiometric
1:1 with CMRglc (72).
i Determined in the human brain during metabolism of (2-13C) acetate (73).
j Determined in vivo as the inverse of the rate constant of 13C labeling in cerebral glutamate C4 during (1-13C) glucose infusions (74 ).
k Determined in the human brain during (1-13C) glucose infusion with a different model than that used in (f–i) (9).
l Only a fraction of glutamine synthesis considered to be derived from neurotransmitter glutamate. Glutamate/glutamine exchange
concluded nonstoichiometric with CMRglc, approaching 0.4 rather than the value of 1 concluded in (f–i) (75 ).
m Determined in the human brain during (1-13C) acetate metabolism (76 ).
n Originally proposed as an -ketoglutarate exchange between the large and small compartments (69).
n.a.: not applicable, n.d.: not detectable.
Adapted from (13). Reproduced with permission of the publisher.
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vitro 13C NMR in a variety of laboratories (26, 41, 60,
61).
Table 2 summarizes values for the tricarboxylic
acid cycle flux, as obtained using different in vivo 13C
NMR approaches compared with earlier radioactive
isotope techniques and in vitro 13C isotopomer ap-
proaches. In general, tricarboxylic acid cycle fluxes
calculated for the adult rat brain were in the range
1.4–0.5 mol  min
1  g
1, depending on the math-
ematical model used for the calculation and the degree
of anesthesia. Values found in rodent brain were
larger than in humans. Table 2 also shows sizes and
turnover rates of the glutamate compartments associ-
ated to the “large” and “small” glutamate pools. No
direct measurements exist to our knowledge of these
pool sizes. The values shown are based on the as-
sumption that the small glutamate pool accounts for
approximately 10% of total cerebral glutamate during
(1-13C) glucose metabolism. Recent evidences indi-
cate that the relative sizes and fractional 13C enrich-
ments of the large and small glutamate pools could
depend on the substrate used (40).
An area of promising development is the clinical
use of 13C MRS. The high cost of the MRS equipment
and 13C isotopes needed for human studies have re-
stricted the use of human 13C MRS to a small number
of laboratories. Despite this, several brain disorders
have been investigated using 13C MRS, which has
already provided new and important clues to clinical
diagnosis. The following physiopathological pro-
cesses have been investigated: (i) in vivo rate of NAA
synthesis (62); (ii) elucidation of mitochondrial brain
disorders (63); (iii) the glutamate-glutamine cycle and
glutamate neurotransmission in certain diseases (64);
and (iv) study of hepatic encephalopathy and impaired
consciousness (65). Additional reviews describing
these topics in more detail can be found in (66–68).
CONCLUSION
The results obtained in the past two decades have
shown that even with a simple 13C MRS methodology
and using conventional substrates such as (1,2-13C2)
glucose and (1,2-13C2) acetate, it is possible to deter-
mine quantitatively metabolic flux through important
metabolic pathways in vivo and in vitro. The use of
heteronuclear labeling strategies and the increasing
power of the associated mathematical modeling may
increase significantly the number of pathways amena-
ble to quantitative analysis by 13C MRS in the near
future. Finally, 13C MRS will still need to overcome
some important challenges. Among these are the
study of intracellular -ketoglutarate/glutamate, the
study of regional metabolism in different brain areas,
the quantitative study of neuronal-glial interactions
and their alteration in different pathologies, the devel-
opment microscopic 13C MRS approaches to unravel
metabolism in a single cell, and the routine applica-
tion of in vivo 13C MRS to clinical studies.
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